Exon sequencing of 409 cancer-related genes in treatment-naïve and multiply-recurrent tumors revealed rare simultaneous mutations in KRAS and SMAD4. In addition, we validated the association between this mutation signature and radioresistance by performing meta-analysis of published in vitro data and isogenic cell-based experiments. The gene discussed is SMAD4; the disease is cancer.